Patents Under Paris © 2006 David W. Opderbeck. Key Provisions National Treatment National Treatment National Treatment National Treatment Right of Priority.

Slides:



Advertisements
Similar presentations
Ato221 - WIPO-UPOV Symp. on IPRs in Plant Biotech., Gva, Article 27.3(b) of the TRIPS Agreement 3.Members may also exclude from patentability:
Advertisements

Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
P ROFESSOR R UTH O KEDIJI First to File Patent Systems How the New U.S. System Compares to other Systems Around the World.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
William Boshnick Greenblum & Bernstein, P.L.C.
Comparison between JP & US new patent systems - First (inventor) to file, exception to loss of novelty, and grace period - NOBUTAKA YOKOTA KYOWA PATENT.
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
Patent Law Overview. Outline Effect of patent protection Effect of patent protection Substantive requirements for patent protection Substantive requirements.
Incorporation by Reference
June 8, 2006 PATENTS: WHAT YOU SHOULD KNOW Steven R. Ludwig, Ph.D., Esq.
FITF Overview and Tips on Responding to Prior Art Rejections Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting United States Patent and.
Patent Strategy Under the AIA Washington in the West January 29, 2013.
Intellectual Property (Patents) Overview P Intellectual Property (Patents) Overview Presented by Jim Parker S aliwanchik L loyd & E isenschenk 3107 S.W.
INTRODUCTION TO PATENT RIGHTS The Business of Intellectual Property
2011 America Invents Act Patent Reform Susan B. Meyer, J.D.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
HOW WILL THE AMERICA INVENTS ACT (AIA) CHANGE THE WAY WE PROTECT AMERICAN IMAGINEERING? Michael A. Guiliana April 24, 2012 Disney’s Grand Californian Hotel.
Intellectual Property Boston College Law School February 16, 2007 Patent - Novelty.
D ANIELS B AKER Introduction to Patent Law Doug Yerkeson University of Cincinnati Senior Design Class April 6, 2005.
Intellectual Property Boston College Law School February 27, 2008 Patent - Enablement.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Anticipation II Patent Law Sept. 16, Novelty § 102 A person is not entitled to a patent if the invention was: in the prior art (as defined by §
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Intellectual Property Boston College Law School February 16, 2009 Patent – Novelty.
Intellectual Property Boston College Law School February 14, 2007 Patent - Utility.
® ® From Invention to Start-Up Seminar Series University of Washington The Legal Side of Things Invention Protection Gary S. Kindness Christensen O’Connor.
PATENT PATENT Present By Hasan Qayyum Chohan.
Lauren MacLanahan Office of Technology Licensing GTRC.
1 35 U.S.C. § 102(e): The Legislative Fix (S.320) and Serial Abandonment of Provisional Applications Stephen G. Kunin Deputy Commissioner for Patent Examination.
© 2010 Hodgson Russ LLP IEEE Southern Area Entrepreneur’s Day Overview Of The Patent Process R. Kent Roberts Hodgson Russ LLP (716)
1 AMERICA INVENTS ACT 報告人:林淑靜 學號: M A New Era ! This Act was signed into law by President Obama on September 16, 2011 and represents first.
0 Charles R. Macedo, Esq. Partner. 1 Brief Overview of Priority Under AIA Implications for Public Disclosures and Private Disclosures Role of Provisional.
Patents- Practical Aspects of International Patent Procurement/Prosecution June 2015 Patent Cooperation Treaty (PCT) Practice Overview.
International IP Issues Federal Lab Consortium Meeting International IP Issues Dr Roisin McNally - European Patent Attorney 20 September 2006.
Soteria Biosciences Foreign Filing Considerations.
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
Investing in research, making a difference. Patent Basics for UW Researchers Leah Haman Intellectual Property Associate WARF 1.
Like.com vs. Ugmode Prosecution history of patent *** CONFIDENTIAL *** Prepared by Ugmode, Inc.
Patents III Novelty and Loss of Rights Class 13 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
© 2008 International Intellectual Property June 22, 2009 Class 6 Patents: Multilateral Agreements (Paris Convention); Economics of International Patent.
Introduction to Patents Anatomy of a Patent & Procedures for Getting a Patent Margaret Hartnett Commercialisation & IP Manager University.
Varian Australia Pty Ltd – Some Patenting Issues David Carmichael 6 th May 2004.
1 INTELECTUAL PROPERTY PATENTS. 2 A patent for an invention grants property rights of that invention to the inventor. It is issued by the Patent and Trademark.
Grace Period System under AIA vs. Exception to Loss of Novelty in Japan JPAA International Activities Center Kazuhiro Yamaguchi January 29, 2013 AIPLA.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Side 1 Andrew Chin AndrewChin.com A Quick Survey of the America Invents Act Patent Law October 12, 2011.
James Toupin – General Counsel February 1, Summary of Proposed Rule Changes to Continuations, Double Patenting, and Claims.
Prior Art  What is prior art?  Prior art = certain types of knowledge defined by 102(a)-(g) that may operate to defeat patentability or invalidate a.
© 2008 International Intellectual Property June 16, 2009 Class 2 Introduction to Patents.
Current Strategies for Patent Development Based on New AIA Patent Law November 21, 2012 J. Scott Southworth1.
2007 Revisions to Japanese Patent Law. 2 #1 Period for Filing Divisional Applications (A) BeforeBefore AfterAfter Notice of Allowance Divisional Application.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
Paris Convention §5A “(1) Importation by the patentee into the country where the patent has been granted of articles manufactured in any of the countries.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
Class 7: Novelty Patent Law Spring 2007 Professor Petherbridge.
The Impact of Patent Reform on Independent Inventors and Start-up Companies Mark Nowotarski (Patent Agent)
 Understand what Novelty is  Know what is called “absolute novelty” and “relative novelty”, and for which types of patents theses notions apply  Know.
Nuts and Bolts of Patent Law presented by: Shamita Etienne-Cummings April 5, 2016.
International Intellectual Property Prof. Manheim Spring, 2007 Patent Utility & Novelty Copyright © 2007.
PCT-FILING SYSTEM.
Patents 101 March 28, 2006 And now, for something new, useful and not obvious.
Paris Convention §5A “(1) Importation by the patentee into the country where the patent has been granted of articles manufactured in any of the countries.
Patent application procedure (…and costs)
Of Counsel Polsinelli, LLP
Nuts and Bolts of Patent Law
Jonathan D’Silva MMI Intellectual Property 900 State Street, Suite 301
Presentation transcript:

Patents Under Paris © 2006 David W. Opderbeck

Key Provisions National Treatment National Treatment National Treatment National Treatment Right of Priority Right of Priority Right of Priority Right of Priority –Within 12 months of filing in a member country, the applicant can file in another member country and priority will relate back to the date of the original filing Independence of National Patents Independence of National Patents Independence of National Patents Independence of National Patents –Invalidation of a patent in one country does not automatically invalidate a patent on the same subject matter in another country Compulsory Licenses and Working Requirements Compulsory Licenses and Working Requirements Compulsory Licenses and Working Requirements Compulsory Licenses and Working Requirements –Still allowed, but minimum period before a compulsory license may be sought for failure to work (3 years from grant or 4 years from app, whichever is longer) –No forfeiture of patent until 2 years after expiration of first compulsory license

Novelty vs. Absolute Novelty – Anesthetic Case (Australia) April 24, 1981 Lancet article – describes use of CPAP to treat adult apnea April 24, 1981 Lancet article – describes use of CPAP to treat adult apnea April 24, 1981 – provisional patent specification filed April 24, 1981 – provisional patent specification filed April 23, 1982 – complete patent specification filed April 23, 1982 – complete patent specification filed November 4, 1982 – patent application published November 4, 1982 – patent application published December 17, 1985 – patent application amended to include claims relating to single-hose technology December 17, 1985 – patent application amended to include claims relating to single-hose technology

Novelty vs. Absolute Novelty – Anesthetic Case (Australia) Australia is absolute novelty jurisdiction (no statutory bar grace period); therefore, if priority date is later than date of publication of Lancet article, the patent claims are anticipated by the Lancet article Australia is absolute novelty jurisdiction (no statutory bar grace period); therefore, if priority date is later than date of publication of Lancet article, the patent claims are anticipated by the Lancet article

Novelty vs. Absolute Novelty – Anesthetic Case (Australia) Applicants argument: (1) the amended application contained new matter (one hose technology) that was not in substance previously disclosed in the prior application; and (2) the complete specification was fairly based on the provisional specification. (The result of this two-step argument is that the priority date for the one-hose technology would be the date of the provisional specification) Applicants argument: (1) the amended application contained new matter (one hose technology) that was not in substance previously disclosed in the prior application; and (2) the complete specification was fairly based on the provisional specification. (The result of this two-step argument is that the priority date for the one-hose technology would be the date of the provisional specification) Respondents argument: applicant then did not properly disclose the best mode of the invention, either at the time of the original filing, or later when the application was amended Respondents argument: applicant then did not properly disclose the best mode of the invention, either at the time of the original filing, or later when the application was amended

Novelty vs. Absolute Novelty – Anesthetic Case (Australia) One tube method is better than two-tube method; however, one-tube method not known to applicant before the date of filing the complete specification (April 23, 1982) and date of publication of application (November 4, 1982), as shown by evidence that after those dates applicant presented at professional conferences two-tube versions of the device; therefore, best mode known at the time was properly disclosed One tube method is better than two-tube method; however, one-tube method not known to applicant before the date of filing the complete specification (April 23, 1982) and date of publication of application (November 4, 1982), as shown by evidence that after those dates applicant presented at professional conferences two-tube versions of the device; therefore, best mode known at the time was properly disclosed –Even if applicant knew of the one hose method by the date of the amended application (November 4, 1982), the relevant date for assessing the adequacy of disclosure is the date of the filing of the complete disclosure (April 23, 1982), because it is from that date that the patent term is measured

Novelty vs. Absolute Novelty – Anesthetic Case (Australia) Other prior art predating the 1982 dates related only to using CPAP to treat premature infants with underdeveloped lungs – held not to anticipate use of CPAP to treat adult apnea Other prior art predating the 1982 dates related only to using CPAP to treat premature infants with underdeveloped lungs – held not to anticipate use of CPAP to treat adult apnea